Stocks›Healthcare›EW

EW

Edwards Lifesciences Corporation
NYSEResearch view

Edwards Lifesciences Corporation operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

$87.23+2.44%
Oct 5 close · 1D EOD · Databento
HealthcareOrthopedic, Prosthetic & Surgical Appliances & SuppliesLarge-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$49.1B
Revenue$6.1B+11.50%
Net income$1.1B
EPS, diluted$1.83−73.70%
Gross margin78.0%
Operating margin20.8%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$49.1B
Enterprise Value$46.7B
Income$1.1B
Sales$6.1B
Book/sh$17.93
Cash/sh$5.10
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio3.09
Current Ratio3.72
Debt/Eq0.06
EPS (ttm)$1.83
EPS this Y-73.7%
EPS past 3/5Y-9.1%
Sales past 3/5Y10.8%
EPS Y/Y TTM-73.7%
Sales Y/Y TTM11.5%
Shs Outstand576.40M
ROA7.8%
ROE10.4%
ROIC13.1%
Gross Margin78.0%
Oper. Margin20.8%
Profit Margin17.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$5.2B
FY21
$4.5B
FY22
$5.0B
FY23
$5.4B
FY24
$6.1B
FY25

Operating leverage — margins

GrossOperatingNet
0%45%90%78%21%18%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.